Metraipolis › archive › dc_16747fb6dc73
Daratumumab plus VRd in Japanese transplant-ineligible/deferred NDMM patients: Japanese subgroup of the CEPHEUS trial — Europe PMC PMID:41894094
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41894094
- DOI
- 10.1007/s12185-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T23:19:44.949Z
- SHA-256 of the archived text
62b1c50fcfc4d7d76738da6d68072e65d96e90b98474e66144d56ed2c5dc4039- Stable URL of this page
https://metraipolis.com/documento/dc_16747fb6dc73
How to cite
Daratumumab plus VRd in Japanese transplant-ineligible/deferred NDMM patients: Japanese subgroup of the CEPHEUS trial — Europe PMC PMID:41894094 — Europe PMC (en), https://europepmc.org/article/MED/41894094 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_16747fb6dc73 (Metraipolis archive dc_16747fb6dc73, sha256 62b1c50fcfc4d7d76738da6d68072e65d96e90b98474e66144d56ed2c5dc4039)
BibTeX
@misc{dc16747fb6dc73,
title = {Daratumumab plus VRd in Japanese transplant-ineligible/deferred NDMM patients: Japanese subgroup of the CEPHEUS trial — Europe PMC PMID:41894094},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41894094},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_16747fb6dc73; sha256 62b1c50fcfc4d7d76738da6d68072e65d96e90b98474e66144d56ed2c5dc4039},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41894094. Agents can read the archived copy with the MCP tool read_document.